BioLife Solutions Stock Forecast

Stock Price Forecast

According to 7 professional analysts, the 12-month price target for BioLife Solutions stock ranges from a low of $27 to a high of $33. The average analyst price target of $30.86 forecasts a 20.17% increase in the stock price over the next year.

Price Target: $30.86 (+20.17%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$27	$30.86	$31	$33
Change	+5.14%	+20.17%	+20.72%	+28.50%

Analyst Ratings

The average analyst rating for BioLife Solutions stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	6	6	5	5	5	5
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $30 → $32	Strong Buy	Maintains	$30 → $32	+24.61%	Aug 8, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $30	Strong Buy	Reiterates	$30	+16.82%	May 13, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $27 → $30	Strong Buy	Maintains	$27 → $30	+16.82%	Mar 6, 2025
Carl Byrnes Northland Capital Markets	Northland Capital Markets	Buy Maintains $28 → $31	Buy	Maintains	$28 → $31	+20.72%	Jan 8, 2025
Robert Wasserman Benchmark	Benchmark	Strong Buy Reiterates $30	Strong Buy	Reiterates	$30	+16.82%	Dec 19, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

99.71M

from 82.25M

21.22%

from 82.25M

Revenue Next Year

117.16M

from 99.71M

17.50%

from 99.71M

EPS This Year

-0.10

from -0.44

EPS Next Year

0.07

from -0.10

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	48.09M	119.16M	76.24M	75.86M	82.25M	99.71M	117.16M	145.91M
Revenue Growth	75.69%	147.79%	-36.02%	-0.50%	8.44%	21.22%	17.50%	24.54%
EPS	-0.06	-0.23	-3.29	-1.56	-0.44	-0.10	0.07	0.51
EPS Growth	-	-	-	-	-	-	-	681.25%
Forward PE	-	-	-	-	-	-	393.38	50.35
No. Analysts	-	-	-	-	-	11	10	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	103.6M	126.4M	151.2M
Avg	99.7M	117.2M	145.9M
Low	95.3M	109.8M	139.3M

Revenue Growth

Revenue Growth	2025	2026	2027
High	26.0%	26.8%	29.0%
Avg	21.2%	17.5%	24.5%
Low	15.8%	10.1%	18.9%

EPS Forecast

EPS	2025	2026	2027
High	-0.06	0.13	0.53
Avg	-0.10	0.07	0.51
Low	-0.14	-0.01	0.49

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	704.2%
Avg	-	-	681.3%
Low	-	-	650.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.